The Feel Good Lab
The Feel Good Lab is giving the OTC pain relief category a much-needed makeover. 1 out of 3 U.S. adults suffers from chronic pain without any healthy options to treat it, until now.
Analytics
Raised to Date: $529,156
Aggregate Commitments $
Netcapital
11/12/2020
03/01/2021
$10,000
$869,999
$100
Equity - Common
RegCF
Pre-Seed
$9,082,500
Weekly Commitments $
Active
02/24/2021
2
5,292%
61%
$5,088
Farmington, Connecticut
Healthcare & Pharmaceuticals
Non-Tech
B2C
Medium
High
The Feel Good Lab, with a post-money valuation of $10.1 million, is raising funds on NetCapital. The company is revolutionizing the OTC pain relief category with its patented healthy pain relief products. The company removed all the toxic ingredients from pain relief medication and developed plant-based products, including healthy pain relief creams. Ryan Gresh, CJ Forse, and Kyle Fitzpatrick founded The Feel Good Lab in 2016. The current round of crowdfunding has a minimum target of $10,000 and a maximum target of $1,069,999, and the funds will be used for sales and marketing, hiring, inventory, R&D, and general and administrative expenses. The Feel Good Lab is backed by the University of Connecticut under the Technology Incubator Program.
Summary Profit and Loss Statement
| Most Recent Year | Prior Year | |
|---|---|---|
|
Revenue |
$242,935 |
$185,157 |
|
COGS |
$123,251 |
$101,651 |
|
Tax |
$0 |
$0 |
| ||
| ||
|
Net Income |
$-333,334 |
$-181,296 |
Summary Balance Sheet
| Most Recent Year | Prior Year | |
|---|---|---|
|
Cash |
$122,711 |
$158,217 |
|
Accounts Receivable |
$20,047 |
$0 |
|
Total Assets |
$259,290 |
$269,217 |
|
Short-Term Debt |
$112,969 |
$0 |
|
Long-Term Debt |
$512,031 |
$0 |
|
Total Liabilities |
$625,000 |
$325,000 |
Ratings
Ratings Platform - Beta Trial
Our new ratings and analytics platform is currently in Beta. To gain access to the Beta platform features, upgrade to a Pro paid account and accept the Beta terms on any page.
For a limited time, use coupon code "TRYMERLIN20" for a free 20 day trial of Kingscrowd Pro and Merlin Beta. Your paid subscription will activate at the end of 20 days. Cancel anytime.Other Deals
MedVector on StartEngine
The COVID-19 pandemic has grown the telehealth industry exponentially. A recent study of U.S medical specialists found that
Phoenix PharmaLabs on Netcapital
In the years before the world’s current COVID-19 crisis, America in particular faced a deadly and persistent threat…
C-Reveal Therapeutics on NetCapital
Cancer is the great, mysterious killer of medical science. As of January 2019, there were an